JRCT ID: jRCT1060210038
Registered date:05/10/2021
Feasibility study of allogeneic mesenchymal stem cell therapy in patients with hypophosphatase
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Hypophosphatasia |
| Date of first enrollment | 05/10/2021 |
| Target sample size | 50 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | HLA matching between commartial bone marrow donor database and participant |
|---|---|
| Secondary Outcome | HLA matching between donor database of Japan Marrow Donor Program and participant |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | < 12age old |
| Gender | Both |
| Include criteria | 1) Diagnosed as hypophosphatasia 2) Under 12 years old 3) Have or have been treated with asphotase alpha 4) Written consent of the surrogate has been obtained for participation in this study. |
| Exclude criteria | none |
Related Information
| Primary Sponsor | Taketani Takeshi |
|---|---|
| Secondary Sponsor | PuREC Co. Ltd. |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Takeshi Taketani |
| Address | 89-1 Enya-cho, Izumo-shi, Shimane, 693-8501 Japan Shimane Japan 693-8501 |
| Telephone | +81-853-20-2220 |
| ttaketani@med.shimane-u.ac.jp | |
| Affiliation | Shimane University |
| Scientific contact | |
| Name | Takeshi Taketani |
| Address | 89-1 Enya-cho, Izumo-shi, Shimane, 693-8501 Japan Shimane Japan 693-8501 |
| Telephone | +81-853-20-2220 |
| ttaketani@med.shimane-u.ac.jp | |
| Affiliation | Shimane University |